Environmental and Lifestyle Correlates of Good Vision in an Elderly Sample

1991 ◽  
pp. 21-33
Author(s):  
A. M. Prestrude ◽  
L. G. Meyer
Keyword(s):  
Good Vision

Vision and driving: is good vision really necessary?

2000 ◽  
Vol 20 (2) ◽  
pp. S22-S23 ◽  
Author(s):  
J Wood
Keyword(s):  
Good Vision

scholarly journals Sympathetic Ophthalmia : A Blinding Complication of Ocular Injury

2005 ◽  
Vol 44 (158) ◽  
Author(s):  
Sudesh Subedi
Keyword(s):  
Early Recognition ◽  
Sympathetic Ophthalmia ◽  
Ocular Injury ◽  
Ocular Complication ◽  
Good Vision

Sympathetic Ophthalmia is a rare and blinding ocular complication due to ocular injury. This condition in amale patient aged 25 years, is reported. The role of early recognition and management of this condition topreserve good vision is discussed.Key Words: Sympathetic ophthalmia, granulomatous panuveitis, ocular injury.

scholarly journals A Comparison Between The (Design-Build DB) and (Design-Bid-Build DBB) Approaches Used in the Jordanian Construction Sector and Clarify the Risks Associated with Each Approach

2021 ◽  
Vol 4 (1) ◽  
pp. 1-12
Author(s):  
Sharaf Al-Deen Waleed AL-Smadi ◽  
Abdalrahman Hammoudah Yousef Alhndawi
Keyword(s):  
Quality Assurance ◽  
Project Management ◽  
Developing Economies ◽  
Construction Sector ◽  
Management Units ◽  
Design Build ◽  
Fair Comparison ◽  
Management Approaches ◽  
Design Bid Build ◽  
Good Vision

The continual need for building in developing economies and countries such as Jordan increases the obstacles and problems faced by Project Management Units in completing projects on time, with quality assurance, and at lower prices. However, as more and more new types of project management approaches such as (Design-Bid DB) are introduced, the binding conditions of contracts are growing tougher in order to reduce risks during project execution. In this paper, the researcher tries to provide a fair comparison between (Design-Bid-Build DBB) and (Design-Build DB) approaches which are already used in the construction project in Jordan and offering a good vision for both owners and contractors equally

scholarly journals The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes

BMJ Open ◽  
2015 ◽  
Vol 5 (5) ◽  
pp. e006535-e006535 ◽  
Author(s):  
T. Butt ◽  
A. Lee ◽  
C. Lee ◽  
A. Tufail ◽  
W. Xing ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Real World ◽  
Economic Model ◽  
Neovascular Amd ◽  
The Cost ◽  
Good Vision

Overview of pharmacological treatments for presbyopia

2021 ◽  
Vol 1 (2) ◽  
pp. 67-77
Author(s):  
Betina Orman ◽  
Giovanna Benozzi
Keyword(s):  
Pharmacological Treatment ◽  
Contact Lenses ◽  
English Literature ◽  
Crystalline Lens ◽  
Surgical Strategies ◽  
Non Invasive ◽  
Near Visual Acuity ◽  
Over 40 Years ◽  
Good Vision

Background: Presbyopia is the normal progressive waning of accommodation with loss of the visual ability to focus on objects residing at different distances. Presbyopia exacts a cost in quality of life and professional efficiency of many people over 40 years of age. Presbyopia is likely to be 1 of the main pressing visual concerns of the 21st century, given that life expectancy is increasing, resulting in an aging population. This review aimed to address the 3 strategies of the pharmacological treatment for presbyopia. Methods: A review on PubMed/MEDLINE, Google Scholar, and Clinicaltrials.gov was performed to investigate the English literature on pharmacological treatment for presbyopia from beginning-of-year 2012 to September 30, 2020. Results: In addition to the treatment of presbyopia with glasses or contact lenses, new surgical strategies have been developed, some of which have been successful. However, during the last decade, a new, promising, non-invasive option for treating presbyopia has emerged: the pharmacological approach. Many researchers have developed 3 different lines of investigation from different assumptions, on a pharmacological basis. The first consisted of producing miosis, to take advantage of a pharmacologically induced pinhole effect, increasing depth-of-focus, and thus improving uncorrected near visual acuity. The second aimed to rehabilitate accommodation binocularly to enable good vision at all distances. Finally, the third approach attempted to rehabilitate lost elasticity in the human crystalline lens. Conclusions: None of the 3 discussed pharmacological strategies for treating presbyopia, prescribed globally, but patients of restoring accommodation strategy can adhere locally, where they are sold so far as master prescriptions.

Correlates of Good Vision in Eyes With Subfoveal Scars From Neovascular Age-Related Macular Degeneration

2018 ◽  
Vol 49 (10) ◽  
pp. 765-774
Author(s):  
Amit Meshi ◽  
Natalia Camacho ◽  
Tiezhu Lin ◽  
Ilkay K. Muftuoglu ◽  
Cheryl A. Arcinue ◽  
...  
Keyword(s):  
Macular Degeneration ◽  
Age Related Macular Degeneration ◽  
Age Related ◽  
Good Vision

Progression to Surgery for Patients With Idiopathic Epiretinal Membranes and Good Vision

2018 ◽  
Vol 49 (10) ◽  
pp. S18-S22
Author(s):  
Xuejing Chen ◽  
Kendra A. Klein ◽  
Chirag P. Shah ◽  
Jeffery S. Heier
Keyword(s):  
Epiretinal Membranes ◽  
Good Vision

scholarly journals Presentation, surgery and 1-year outcomes of childhood cataract surgery in Tanzania

2020 ◽  
pp. bjophthalmol-2020-316042
Author(s):  
Furahini Godfrey Mndeme ◽  
Blandina Theophyl Mmbaga ◽  
Mchikirwa Msina ◽  
Judith Mwende ◽  
Sonia J Vaitha ◽  
...  
Keyword(s):  
Visual Acuity ◽  
Low Income ◽  
Visual Outcome ◽  
Low Income Countries ◽  
Similar Proportion ◽  
Poor Visual Outcome ◽  
A Prospective Study ◽  
Good Vision ◽  
Childhood Cataract

BackgroundRecent reports have suggested a significant change in the causes of blindness in children in low-income countries cataract becoming the leading cause. We aimed to investigate the presentations and surgical outcomes in children with cataract operated at different ages in Tanzania.MethodsWe conducted a prospective study of 228 children aged ≤192 months at three tertiary centres, 177 with bilateral cataracts and prospectively followed them for 1-year postsurgery. We collected demographic, surgical, preoperative and postoperative clinical characteristics using the standard childhood cataract surgical assessment questionnaire. Families were encouraged to return for follow-up by phone with travel reimbursement where necessary.ResultsPreoperatively, 76% bilateral children were blind in the better eye. 86% of children were followed up at 1 year and 54% bilateral children achieved visual acuity of 0.48 logMAR or better in the better eye and 5% were blind. 33% of unilateral children achieved visual acuity of 0.48 logMAR or better and 17% were blind. Preoperative blindness (adjusted OR (AOR) 14.65; 95% CI 2.21 to 97.20), preoperative nystagmus/strabismus (AOR 9.22; 95% CI 2.66 to 31.97) and aphakia (AOR, 5.32; 95% CI 1.05 to 26.97) predicted poor visual outcome in bilateral cases. 9% of 342 refracted eyes had initial postoperative cylinder of 1.5 D or more, as did a similar proportion (11%) of 315 eyes refracted 1 year after surgery. Acute fibrinous uveitis occurred in 41 (12%) eyes.ConclusionThree-quarters of children were blind preoperatively whereas over half had good vision 1-year postoperatively. Preoperative blindness, nystagmus/strabismus and aphakia predicted poor visual outcome, suggesting that cataract density determines density of amblyopia.

scholarly journals Ten-year survival trends of neovascular age-related macular degeneration at first presentation

2020 ◽  
pp. bjophthalmol-2020-317161
Author(s):  
Cristina Arpa ◽  
Hagar Khalid ◽  
Shruti Chandra ◽  
Siegfried Wagner ◽  
Katrin Fasler ◽  
...  
Keyword(s):  
Macular Degeneration ◽  
Age Related Macular Degeneration ◽  
Visual Outcomes ◽  
Anti Vegf ◽  
Kaplan Meier ◽  
Age Related ◽  
Treatment Naïve ◽  
Mean Trend ◽  
Endothelial Growth Factor ◽  
Good Vision

BackgroundTo describe 10-year trends in visual outcomes, anatomical outcomes and treatment burden of patients receiving antivascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD).MethodsRetrospective cohort study of treatment-naïve, first-affected eyes with nAMD started on ranibizumab before January 1, 2009. The primary outcome was time to best-corrected visual acuity (BCVA) falling ≤35 ETDRS letters after initiating anti-VEGF therapy. Secondary outcomes included time to BCVA reaching ≥70 letters, proportion of eyes with BCVA ≥70 and ≤35 letters in 10 years, mean trend of BCVA and central retinal thickness over 10 years, and mean number of injections.ResultsFor our cohort of 103 patients, Kaplan-Meier analyses demonstrated median time to BCVA reaching ≤35 and ≥70 letters were 37.8 (95% CI 22.2 to 65.1) and 8.3 (95% CI 4.8 to 20.9) months after commencing anti-VEGF therapy, respectively. At the final follow-up, BCVA was ≤35 letters and ≥70 letters in 41.1% and 21%, respectively, in first-affected eyes, while this was the case for 5.4% and 48.2%, respectively, in a patient’s better-seeing eye. Mean injection number was 37.0±24.2 per eye and 53.6±30.1 at patient level (63.1% of patients required injections in both eyes).ConclusionsThe chronicity of nAMD disease and its management highlights the importance of long-term visual prognosis. Our analyses suggest that one in five patients will retain good vision (BCVA ≥70 ETDRS letters) in the first-affected eye at 10 years after starting anti-VEGF treatment; yet, one in two patients will have good vision in their better-seeing eye. Moreover, our data suggest that early treatment of nAMD is associated with better visual outcomes.

Sign in / Sign up

Export Citation Format

Share Document